Value of labetalol assisted magnesium sulfate in the treatment of patients with pregnancy-induced hypertension
拉贝洛尔辅助硫酸镁治疗妊高症患者的价值

摘要

目的 分析妊高症患者实施拉贝洛尔辅助硫酸镁治疗的价值。方法 采用2022年3月-2023年3月我院收治的69例妊高症患者，随机分为对照组35例，观察组34例，分别实行常规硫酸镁治疗、拉贝洛尔辅助硫酸镁治疗，对两组血压指标（收缩压、舒张压）、不良母婴结局（产后感染、产后出血、胎盘早剥、新生儿窒息）及并发症（子宫收缩、宫颈裂伤、子痫）发生情况比较。结果 与对照组相较，观察组收缩压、舒张压更低，不良母婴结局发生率、并发症发生率更低，差异均有统计学意义（P＜0.05）。结论 妊高症患者实施拉贝洛尔辅助硫酸镁治疗应用价值高，有效改善患者血压指标，降低不良母婴结局发生率，减少并发症，治疗安全性较高，具有推广价值。

Abstract

Objective To analyze the value of implementing rabelol assisted magnesium sulfate treatment in patients with preeclampsia.
Methods A total of 69 patients with preeclampsia admitted to our hospital from March 2022 to March 2023 were randomly divided into a control group of 35 cases and an observation group of 34 cases. The two groups were treated with conventional magnesium sulfate therapy and labelol assisted magnesium sulfate therapy, respectively. The blood pressure indicators (systolic and diastolic blood pressure), adverse maternal and infant outcomes (postpartum infection, postpartum hemorrhage, placental abruption, neonatal asphyxia), and incidence of complications (uterine contractions, cervical lacerations, and eclampsia) were compared between the two groups.
Results Compared with the control group, the observation group had lower systolic and diastolic blood pressure, lower incidence of adverse maternal and infant outcomes, and lower incidence of complications, with statistical significance (P<0.05).
Conclusion   The application value of Labelol assisted magnesium sulfate treatment in patients with preeclampsia is high, which effectively improves blood pressure indicators, reduces the incidence of adverse maternal and infant outcomes, reduces complications, and has high treatment safety. It has promotional value.